Sansure Biotech Inc. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 632.54 million compared to CNY 4,068.23 million a year ago. Revenue was CNY 632.54 million compared to CNY 4,068.23 million a year ago.

Net income was CNY 299.72 million compared to CNY 1,598.37 million a year ago. Basic earnings per share from continuing operations was CNY 0.51 compared to CNY 2.74 a year ago. Diluted earnings per share from continuing operations was CNY 0.51 compared to CNY 2.74 a year ago.